Citigroup’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.27M | Buy |
384,891
+355,614
| +1,215% | +$4.87M | ﹤0.01% | 1380 |
|
|
2025
Q1 | $324K | Sell |
29,277
-8,733
| -23% | -$96.6K | ﹤0.01% | 3159 |
|
|
2024
Q4 | $405K | Buy |
38,010
+9,882
| +35% | +$105K | ﹤0.01% | 3161 |
|
|
2024
Q3 | $357K | Buy |
28,128
+19,796
| +238% | +$251K | ﹤0.01% | 3202 |
|
|
2024
Q2 | $140K | Buy |
8,332
+3,494
| +72% | +$58.6K | ﹤0.01% | 3340 |
|
|
2024
Q1 | $72.6K | Sell |
4,838
-13,846
| -74% | -$208K | ﹤0.01% | 3703 |
|
|
2023
Q4 | $280K | Buy |
18,684
+18,278
| +4,502% | +$274K | ﹤0.01% | 3035 |
|
|
2023
Q3 | $5.69K | Sell |
406
-5,818
| -93% | -$81.5K | ﹤0.01% | 3960 |
|
|
2023
Q2 | $64.4K | Sell |
6,224
-48,686
| -89% | -$504K | ﹤0.01% | 3820 |
|
|
2023
Q1 | $507K | Buy |
54,910
+295
| +0.5% | +$2.73K | ﹤0.01% | 2527 |
|
|
2022
Q4 | $484K | Buy |
54,615
+54,284
| +16,400% | +$481K | ﹤0.01% | 2557 |
|
|
2022
Q3 | $3K | Sell |
331
-410
| -55% | -$3.72K | ﹤0.01% | 4625 |
|
|
2022
Q2 | $6K | Sell |
741
-486
| -40% | -$3.94K | ﹤0.01% | 4807 |
|
|
2022
Q1 | $11K | Sell |
1,227
-4,385
| -78% | -$39.3K | ﹤0.01% | 4706 |
|
|
2021
Q4 | $53K | Buy |
5,612
+2,169
| +63% | +$20.5K | ﹤0.01% | 4271 |
|
|
2021
Q3 | $58K | Buy |
3,443
+1,138
| +49% | +$19.2K | ﹤0.01% | 3919 |
|
|
2021
Q2 | $35K | Buy |
2,305
+574
| +33% | +$8.72K | ﹤0.01% | 4319 |
|
|
2021
Q1 | $34K | Sell |
1,731
-2,695
| -61% | -$52.9K | ﹤0.01% | 4269 |
|
|
2020
Q4 | $80K | Buy |
4,426
+2,173
| +96% | +$39.3K | ﹤0.01% | 3826 |
|
|
2020
Q3 | $43K | Sell |
2,253
-4,751
| -68% | -$90.7K | ﹤0.01% | 3570 |
|
|
2020
Q2 | $183K | Buy |
7,004
+245
| +4% | +$6.4K | ﹤0.01% | 3121 |
|
|
2020
Q1 | $121K | Buy |
6,759
+1,376
| +26% | +$24.6K | ﹤0.01% | 3179 |
|
|
2019
Q4 | $180K | Buy |
5,383
+3,881
| +258% | +$130K | ﹤0.01% | 3201 |
|
|
2019
Q3 | $35K | Sell |
1,502
-4,230
| -74% | -$98.6K | ﹤0.01% | 3958 |
|
|
2019
Q2 | $206K | Buy |
5,732
+5,424
| +1,761% | +$195K | ﹤0.01% | 3198 |
|
|
2019
Q1 | $11K | Buy |
+308
| New | +$11K | ﹤0.01% | 4738 |
|